EP0071433A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Medicine for the treatment of diabetes
Assignee: Kowa Co Ltd
•
Filing: 1982-07-23
•
Granted: —
•
Expires: 2002-07-23
Abstract
Abstract A medicine for the treatment of diabetes which comprises insulin and a synthetic phenyl ester type chymotrypsin inhibitor is effectively useful for absorption of insulin through the intestinal canal without the deactivation of insulin in the canal.
Inventors
- 👤 Setsuro Fujii
- 👤 Eizou Hattori
- 👤 Mitsuteru Hirata
- 👤 Koichiro Watanabe
- 👤 Hiroshi Ishihama
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-30 18:37
CPC Classifications
C; C07; C07D; C07D295/00; C07D295/16; C07D295/18; C07D295/182; C07D295/185; A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/22; A61K38/28; C07D209/00; C07D209/02; C07D209/04; C07D209/10; C07D209/18; C07D295/04; C07D295/08; C07D295/084; C07D295/088; C07D295/192
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
26 words
A method of preparing a medicine for the treatment of diabetes, characterised by the step of admixing insulin and a synthetic phenyl ester type chymotrypsin inhibitor.
Claim 2
Independent Claim
26 words
A method of preparing a medicine for the treatment of diabetes, characterised by the step of admixing insulin and a synthetic phenyl ester type chymotrypsin inhibitor.
Claim 3
Dependent Claim
260 words
The method according to claim 1, characterised in that said synthetic phenyl ester type chymotrypsin inhibitor is a compound represented by the following formula or an acid addition salt thereof, wherein R: indole which may be substituted with lower alkyl and/or lower alkoxy; naphthyl which may be substituted with lower alkoxy and which may be partially saturated with 2 or 4 hydrogen atoms; phenyl which may be substituted with lower alkyl, alkoxy, alkoxycarbonyloxy; acyl, acyloxy or halogen; cyclohexyl; or indane or furyl; A: a single bond, alkylene or vinylene; P: a single bond, alkylene, vinylene or alkylene attached to the benzene ring through an oxygen or nitrogen atom in which said alkylene group may be substituted with amino, alkylamino or benzoyloxyamino, and said nitrogen atom may be substituted with acyl; and in which R 1 and R 2 are same or different, and represents hydrogen, lower alkyl, acyl, aminoalkyl or aminoacyloxyalkyl; in which R 3 represents lower alkyl, cyclo alkyl, benzyl, carbamoyl lower alkyl,-morpholinocarbonyl lower alkyl, pyrrolidinocarbonyl lower alkyl, piperidinocarbonyl lower alkyl, piperidino lower alkyl, anilinocarbonyl lower alkyl, alkylaminocarbonyl lower alkyl or alkoxycarbonyl lower alkyl; -OR 4 in which R 4 represents hydrogen, lower alkyl, aralkyl, succinimido, aminoacyloxyalkyl, aminoalkyloxyalkyl or aminoalkylcarbamoylalkyl; - N H-alkylene- in which R 5 represents lower alkyl, morpholine lower alkyl, morpholinocarbonyl lower alkyl, pyrrodinocarbonyl lower alkyl, piperidinocarbonyl lower alkyl or lower alkylaminocarbonyl lower alkyl; or in which Q represents straight-chain or branched-chain alkylene, R 6 and R 7 each represent lower alkyl, or both jointly form, together with an adjacent nitrogen atom, pyrrolidino, piperidino or morpholino.
Claim 4
Dependent Claim
36 words
The method according to claim 1 or claim 2, characterised in that said synthetic phenyl ester type chymotrypsin inhibitor is present in an amount of 0.1 to 10 mg based on one unit of said insulin.
References Cited (Backward Citations)
US4156719A
Cited
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.